Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Closed 11-25 16:00:00 EST

337.82

+0.07

+0.02%

盘后337.82

+0.00+0.00%

19:21 EST

High350.56	Low337.33	Vol306.77K
Open341.65	D1 Closing337.75	Amplitude3.92%
Mkt Cap10.48B	Tradable Cap8.60B	Total Shares31.01M
T/O104.70M	T/O Rate1.20%	Tradable Shares25.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":337.82,"timestamp":1732568400000,"preClose":337.75,"halted":0,"volume":306769,"hourTrading":{"tag":"盘后","latestPrice":337.8216,"preClose":337.82,"latestTime":"19:21 EST","volume":7446,"amount":2515404.4403,"timestamp":1732580512973},"delay":0,"floatShares":25468158,"shares":31011528,"eps":11.422568,"marketStatus":"Closed","change":0.07,"latestTime":"11-25 16:00:00 EST","open":341.65,"high":350.559,"low":337.33,"amount":104695944.79957,"amplitude":0.039168,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":11.422568,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732611600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":337.75,"preHourTrading":{"tag":"盘前","latestPrice":339.65,"preClose":337.75,"latestTime":"08:50 EST","volume":778,"amount":263587.31804,"timestamp":1732542620295},"postHourTrading":{"tag":"盘后","latestPrice":337.8216,"preClose":337.82,"latestTime":"19:21 EST","volume":7446,"amount":2515404.4403,"timestamp":1732580512973},"volumeRatio":0.624549,"impliedVol":0.3539,"impliedVolPercentile":0.4087},"requestUrl":"/m/hq/s/MEDP/tweets","defaultTab":"tweets","newsList":[{"id":"2486867370","title":"Medpace Holdings Is Maintained at Neutral by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2486867370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486867370?lang=en_us&edition=fundamental","pubTime":"2024-11-25 21:01","pubTimestamp":1732539660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2024 08:01 ET (13:01 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"gpt_icon":0},{"id":"2486085114","title":"Medpace price target raised to $354 from $349 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2486085114","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486085114?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:20","pubTimestamp":1732537220,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Medpace (MEDP) to $354 from $349 and keeps a Neutral rating on the shares. The firm said the sector chop, p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-price-target-raised-to-354-from-349-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-price-target-raised-to-354-from-349-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2486773764","title":"U.S. RESEARCH ROUNDUP-Domino's Pizza, Elastic NV, Snowflake","url":"https://stock-news.laohu8.com/highlight/detail?id=2486773764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486773764?lang=en_us&edition=fundamental","pubTime":"2024-11-25 15:05","pubTimestamp":1732518328,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Domino's Pizza, Elastic NV, SnowflakeNov 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Domino","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nL3N3MW0BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","TGTX","BK4527","LU0251131958.USD","LU1046421795.USD","LU0154245673.USD","LU1496350171.SGD","SNOW","LU1201861249.SGD","SLG","BK4503","ESTC","LU0426412945.USD","LU1923623000.USD","LU1989764748.USD","SDHC","PD","LU0251142724.SGD","LU2063271972.USD","DPZ","LU0640476718.USD","THO","LU0130102774.USD","CCAP","LU1201861165.SGD","BK4139","LU0949170772.SGD","LU1803068979.SGD","INTU","CRL","LU0289961442.SGD","LU0792757196.USD","BK4532","LU1548497426.USD","LU1551013425.SGD","LU2089284900.SGD","LU0345774631.USD","LU0082616367.USD","LU0823434740.USD","CRM","BK4099","ROK","MEDP","IQV","FSK","FTRE","IE00BQXX3C00.GBP","DXLG","BK4588"],"gpt_icon":1},{"id":"2485245728","title":"Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2485245728","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485245728?lang=en_us&edition=fundamental","pubTime":"2024-11-23 03:06","pubTimestamp":1732302364,"startTime":"0","endTime":"0","summary":"Today we're going to take a look at the well-established Medpace Holdings, Inc. ( NASDAQ:MEDP ). The company's stock...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-medp/medpace-holdings/news/is-now-the-time-to-look-at-buying-medpace-holdings-inc-nasda-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","BK4112","TQQQ","SQQQ","MEDP","LU2210150020.SGD","MNQmain","LU2065169927.USD","NQmain","BK4588","QID","BK4121","BK4585","IE00B64PRP62.GBP","PSQ","LU2095319765.USD","IE00BKPKM429.USD","QLD","LU2210149790.SGD","LU2065171311.SGD","IE00BGHQF748.EUR","LU2065171402.SGD","IE00B3QW5Z07.USD","LU2065170008.USD","NDAQ"],"gpt_icon":1},{"id":"2481970940","title":"When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481970940","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481970940?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:20","pubTimestamp":1730978416,"startTime":"0","endTime":"0","summary":"Let's talk about the popular Medpace Holdings, Inc. . The company's shares saw a decent share price growth of 14% on the NASDAQGS over the last few months. While good news for shareholders, the company has traded much higher in the past year. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, what if the stock is still a bargain?Let’s examine Medpace Holdings’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Medpace Holdings' earnings over the next few years are expected to increase by 35%, indicating a highly optimistic future ahead. This sho","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/buy-medpace-holdings-inc-nasdaq-112016898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","BK4585",".IXIC","IE00BKPKM429.USD","BK4588","SQQQ","IE00B64PRP62.GBP","LU2065171311.SGD","LU2095319765.USD","LU2065169927.USD","LU2065170008.USD","NDAQ","MEDP","NQmain","QID","PSQ","LU2065171402.SGD","LU2210149790.SGD","BK4112","MNQmain","IE00BGHQF748.EUR","TQQQ","IE00B3QW5Z07.USD","LU2210150020.SGD","QLD"],"gpt_icon":1},{"id":"2480800255","title":"What Makes Medpace Holdings (MEDP) a Good Holding?","url":"https://stock-news.laohu8.com/highlight/detail?id=2480800255","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480800255?lang=en_us&edition=fundamental","pubTime":"2024-11-04 23:12","pubTimestamp":1730733160,"startTime":"0","endTime":"0","summary":"Giverny Capital Asset Management, LLC, an investment management company, recently published its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The portfolio returned 6.99% in the third quarter compared to a 5.89% return for the S&P 500 Total Return Index. The fund returned 20.16% year-to-date compared to the 22.08% return for the Index during the same period. The strategy continued to benefit from the exceptionally robust US stock market. For more information on the fund’s top picks in 2024, please check its top five holdings.Giverny Capital Asset Management stated the following regarding Medpace Holdings, Inc.  in its Q3 2024 investor letter:. Medpace is respected by the market and never trades for a cheap price. Our partners at Giverny Capital Inc. in Montreal bought some in 2023 for about 25 times the forward earnings estimate. I felt at the time that I did not understand the business well enough to buy it for us. We’ve spent a fair amount of time s","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/iFLBrImwDWdo5RzBkhehJQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4e7d4156e21c19cbd6b25347626139ce","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/iFLBrImwDWdo5RzBkhehJQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4e7d4156e21c19cbd6b25347626139ce"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/makes-medpace-holdings-medp-good-151240307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171311.SGD","QID","MNQmain","LU2065169927.USD","LU2065170008.USD","BK4588","QLD","TQQQ","MEDP","PSQ","BK4585","SQQQ",".IXIC","NQmain","BK4121","LU2065171402.SGD"],"gpt_icon":1},{"id":"2480623848","title":"Medpace: A Compelling Long-Term Opportunity Amid Short-Term Headwinds (Rating Upgrade)","url":"https://stock-news.laohu8.com/highlight/detail?id=2480623848","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480623848?lang=en_us&edition=fundamental","pubTime":"2024-11-02 00:15","pubTimestamp":1730477724,"startTime":"0","endTime":"0","summary":"Medpace has experienced short-term headwinds, driven by unexpectedly high cancellations and funding issues among smaller biotechnology businesses.Although sales growth underperformed overall expectati","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1867575565/image_1867575565.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1867575565/image_1867575565.jpg"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4732083-medpace-a-compelling-long-term-opportunity-amid-short-term-headwinds","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MEDP"],"gpt_icon":0},{"id":"2478979296","title":"Medpace: Buy The Short-Term Pain For Long-Term Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2478979296","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478979296?lang=en_us&edition=fundamental","pubTime":"2024-10-26 20:00","pubTimestamp":1729944042,"startTime":"0","endTime":"0","summary":"Medpace Holdings' stock fell after Q3 earnings due to revenue growth concerns and a low book-to-bill ratio, but the long-term prospects remain strong.Medpace offers full-service clinical trial management, catering mainly to small biopharma companies lacking trial expertise, making it a stand-out player in the CRO market.Maskot Medpace Holdings , a contract research organization [CRO], recently fell after its Q3 earnings report. There are concerns about slowing revenue growth and a relatively low net book-to-bill ratio. However, these are short-term concerns. The long-term outlook for Medpace remains bright, and now, the stock is reasonably priced. Further, Medpace is a very high-quality company with consistently solid profitability and growth metrics. Therefore, I view MEDP stock as a Buy. What Does Medpace Do?","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345022914/image_1345022914.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345022914/image_1345022914.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4729867-medpace-buy-the-short-term-pain-for-long-term-gains","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4585","BK4588","LU2065169927.USD","LU2065171402.SGD","BK4121","MEDP","LU2065170008.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2477559828","title":"Medpace cut to neutral by Baird, slowed revenue growth cited","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559828","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477559828?lang=en_us&edition=fundamental","pubTime":"2024-10-24 00:46","pubTimestamp":1729701991,"startTime":"0","endTime":"0","summary":"Adam Gault Baird downgraded Medpace (NASDAQ:MEDP) to neutral, citing slowed near-term revenue growth. Baird said that while 2025 may see low single digit to mid-single digit revenue growth, if bookings recover in the second half of 2025, “then 2026 could easily return to double-digit","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/88621226/image_88621226.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/88621226/image_88621226.jpg?io=getty-c-w750"],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4196472-medpace-cut-to-neutral-by-baird-slowed-revenue-growth-cited","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["MEDP"],"gpt_icon":0},{"id":"2477130623","title":"Baird Downgrades Medpace to Neutral From Outperform, Adjusts Price Target to $349 From $413","url":"https://stock-news.laohu8.com/highlight/detail?id=2477130623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477130623?lang=en_us&edition=fundamental","pubTime":"2024-10-23 17:54","pubTimestamp":1729677290,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) has an average rating of outperform and price targets ranging from $296 to $404, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"gpt_icon":0},{"id":"2477330569","title":"Cautious Near-Term Outlook for Medpace Holdings with Potential Growth Recovery by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2477330569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477330569?lang=en_us&edition=fundamental","pubTime":"2024-10-23 17:16","pubTimestamp":1729674993,"startTime":"0","endTime":"0","summary":"Robert W. Baird analyst Eric Coldwell downgraded the rating on Medpace Holdings (MEDP – Research Report) to a Hold today, setting a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cautious-near-term-outlook-for-medpace-holdings-with-potential-growth-recovery-by-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cautious-near-term-outlook-for-medpace-holdings-with-potential-growth-recovery-by-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2065170008.USD","BK4094","BK4588","LU2065169927.USD","LU2065171311.SGD","MEDP","LU2065171402.SGD","XELB","BK4121"],"gpt_icon":0},{"id":"2477308086","title":"Medpace downgraded to Neutral from Outperform at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2477308086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477308086?lang=en_us&edition=fundamental","pubTime":"2024-10-23 16:55","pubTimestamp":1729673717,"startTime":"0","endTime":"0","summary":"Baird downgraded Medpace (MEDP) to Neutral from Outperform with a price target of $349, down from $413. The firm says it is hard to see Medpace get...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-downgraded-to-neutral-from-outperform-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-downgraded-to-neutral-from-outperform-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2477874377","title":"Optimistic Outlook for Medpace Holdings Amid Strong Financial Performance and Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2477874377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477874377?lang=en_us&edition=fundamental","pubTime":"2024-10-23 16:35","pubTimestamp":1729672514,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Ann Hynes has maintained their bullish stance on MEDP stock, giving a Buy rating yesterday. Ann Hynes has given her Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/optimistic-outlook-for-medpace-holdings-amid-strong-financial-performance-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/optimistic-outlook-for-medpace-holdings-amid-strong-financial-performance-and-strategic-initiatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2065169927.USD","BK4121","LU2065171311.SGD","MEDP","LU2065171402.SGD","LU2065170008.USD","BK4588"],"gpt_icon":0},{"id":"2477137142","title":"Q3 2024 Medpace Holdings Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2477137142","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477137142?lang=en_us&edition=fundamental","pubTime":"2024-10-23 15:56","pubTimestamp":1729670168,"startTime":"0","endTime":"0","summary":"Lauren Morris; Director of Investor Relations; Medpace Holdings Inc. August Troendle; Chairman of the Board, Chief Executive Officer; Medpace Holdings Inc. Kevin Brady; Chief Financial Officer, Treasurer; Medpace Holdings Inc. Eric Coldwell; Analyst; Robert W. Baird & Co. Incorporated.Good day, ladies and gentlemen and welcome to the Medpace third quarter 2024 earnings conference call  As a reminder, this call may be recorded. I would now like to introduce your host for today's conference call. Lauren Morris, Medpace's Director of Investor Relations. You may be begin.Good day. Backlog cancellations in Q3 were above our usual range, making for three consecutive quarters of elevated cancellations. The magnitude of cancellations in Q3 were comparable to Q1 and improved relative to Q2. As a net result of the elevated cancellations experienced in Q1 through Q3. Net new business awards were depressed in Q3 generating a net book to bill ratio of 1.0 for the quarter. As ment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-medpace-holdings-inc-075608493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MEDP"],"gpt_icon":0},{"id":"2477320882","title":"U.S. RESEARCH ROUNDUP-BXP, Medpace Holdings, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2477320882","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477320882?lang=en_us&edition=fundamental","pubTime":"2024-10-23 14:34","pubTimestamp":1729665243,"startTime":"0","endTime":"0","summary":"Oct 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including BXP, Medpace Holdings and Starbucks, on Wednesday.   HIGHLIGHTS   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BANC","LU0054578231.USD","SHW","PHM","PATH","MDLZ","VNO","DHR","LU0320765489.SGD","BK4212","LU1551013342.USD","WTFC","EWBC","IBTX","RHI","PATK","PII","LU1923621640.USD","SBUX","CSGP","BK4166","GM","CADE","ENVA","PEBO","LU0114720955.EUR","SLB","MDGL","LU0823411888.USD","MEDP","BK4187","BK4127","BXP","FI","PM","SG9999001176.USD","ZION","IQV","GPC","INCY","HSBC","BK4112","LU2404859667.USD","IE000M9KFDE8.USD","LU1551013425.SGD","TW","LU0353189763.USD","HSY"],"gpt_icon":1},{"id":"2477034096","title":"Medpace Holdings Inc : Jefferies Cuts Target Price to $305 From $345","url":"https://stock-news.laohu8.com/highlight/detail?id=2477034096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477034096?lang=en_us&edition=fundamental","pubTime":"2024-10-23 12:04","pubTimestamp":1729656296,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241023:nFWN3LY1KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","LU2065171311.SGD","BK4585","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","BK4588","MEDP"],"gpt_icon":0},{"id":"2477573293","title":"Why Is Medpace Stock Diving On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2477573293","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477573293?lang=en_us&edition=fundamental","pubTime":"2024-10-23 00:07","pubTimestamp":1729613267,"startTime":"0","endTime":"0","summary":"Medpace Holdings reports Q3 results with revenue of $533.3M, below consensus. Backlog and EBITDA increased. Medspace lowered its FY24 revenue forecast.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41460336/why-is-medpace-stock-diving-on-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","AMID","BK4121","LU2065170008.USD","LU2065169927.USD","BK4588","BK4585","MEDP","HELX","LU2065171311.SGD"],"gpt_icon":0},{"id":"2477041355","title":"How Medpace Just Blew Up Expectations For Double-Digit Sales Growth In 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2477041355","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477041355?lang=en_us&edition=fundamental","pubTime":"2024-10-22 22:10","pubTimestamp":1729606208,"startTime":"0","endTime":"0","summary":"Medpace stock tumbled Tuesday on a series of third-quarter misses that could spell disaster for its 2025 growth prospects.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2021/02/Stock-drugTest-09-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2021/02/Stock-drugTest-09-adobe-150x150.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/medpace-stock-medpace-earnings-q3-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["MEDP"],"gpt_icon":0},{"id":"2477583833","title":"Medpace Stock Drop. Biotech's Doldrums Are to Blame. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2477583833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477583833?lang=en_us&edition=fundamental","pubTime":"2024-10-22 22:09","pubTimestamp":1729606140,"startTime":"0","endTime":"0","summary":"The crisis that has swept the biotech sector crashed into Medpace Holdings on Tuesday, sending shares of the drug-testing company down more than 13% in morning trading.Medpace, which runs clinical trials of experimental medicines on behalf of drugmakers, revealed third-quarter results late Monday that implied weaker-than-expected demand from drugmakers.On an investor call Tuesday morning, Medpace CEO August Troendle said the company had seen higher-than-normal levels of cancellations in the third quarter, an issue that has dogged the company throughout the year.Troendle blamed the cancellations on biotechs running out of cash.\"We've never seen a period in which we had across-the-board elevated cancellations that weren't just kind of one-off,\" Troendle said. \"I don't see any trend across therapeutic areas or anything like that. The only common factor is that these were companies that were funded during the Covid high, and have run out of money.\". Even now, three years after the biotech ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","LU2065170008.USD","BK4585","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD","BK4121","BK4588"],"gpt_icon":0},{"id":"2477333279","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Medpace Holdings (MEDP), Biohaven Ltd. (BHVN) and Intra-Cellular Therapies (ITCI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2477333279","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477333279?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:10","pubTimestamp":1729599027,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medpace Holdings (MEDP – Research Report), Biohave...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-medpace-holdings-medp-biohaven-ltd-bhvn-and-intra-cellular-therapies-itci?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-medpace-holdings-medp-biohaven-ltd-bhvn-and-intra-cellular-therapies-itci?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4121","BK4588","BK4137","LU0320765992.SGD","HCSG","BK4139","LU2065171311.SGD","LU2065169927.USD","LU0889565916.HKD","LU0109394709.USD","BHVN","LU1093756325.SGD","LU1093756168.USD","MEDP","ITCI","LU2065170008.USD","LU2065171402.SGD","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":0.0873},{"period":"1month","weight":0.0233},{"period":"3month","weight":-0.136},{"period":"6month","weight":-0.1352},{"period":"1year","weight":0.2199},{"period":"ytd","weight":0.1018}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.002999},{"month":2,"riseRate":0.375,"avgChangeRate":-0.008443},{"month":3,"riseRate":0.75,"avgChangeRate":0.009421},{"month":4,"riseRate":0.625,"avgChangeRate":0.004841},{"month":5,"riseRate":0.5,"avgChangeRate":0.028287},{"month":6,"riseRate":1,"avgChangeRate":0.07563},{"month":7,"riseRate":0.625,"avgChangeRate":0.121468},{"month":8,"riseRate":0.625,"avgChangeRate":0.022801},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.013974},{"month":10,"riseRate":0.444444,"avgChangeRate":0.048648},{"month":11,"riseRate":0.666667,"avgChangeRate":0.061845},{"month":12,"riseRate":0.875,"avgChangeRate":0.041111}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}